CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Italy

Date: 2016-08

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Italy


GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Italy”. The report is an essential source of information and analysis on Italy’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and the country’s healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the Italian pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

Italy’s population was 61.78 million in 2015, and is increasing due to a positive balance between the birth and death rates, as well as through immigration. The country’s policymakers are currently faced with the challenge of an increasing unemployment rate due to a lack of clear monetary policies. The pharmaceutical market at the consumer price level (including Value Added Tax (VAT) and excluding hospital sales) was estimated at $22 billion in 2015, and is expected to decline to approximately $18 billion by 2020, at a negative Compound Annual Growth Rate (CAGR) of 3.3%. The medical devices market was estimated at approximately $13.2 billion in 2015, and is expected to reach $16.2 billion by 2020, at a CAGR of 4.2%. The decline of Italy’s pharmaceutical market can primarily be attributed to –
– Owing to government measures to decrease healthcare expenditure
– Falling sales of patented drugs,
– Price cuts for drugs
– Government initiatives to promote generics
– The strict pricing of drugs through negotiations and through external reference pricing and internal reference pricing


The report provides information on Italy’s healthcare, regulatory and reimbursement landscape, and includes –
– An overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical and medical devices market. The major players covered for the pharmaceutical market are Menarini, Angelini, Chiesi, Bracco and Recordati. The major players covered for the medical devices market are DePuy Synthes, GlaxoSmithKline (GSK), Baxter, Essilor and Siemens Healthcare
– An insightful review of the country’s reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs
– Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure
– An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to –
– Develop business strategies by understanding the trends shaping and driving Italy’s healthcare market
– Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Italy’s healthcare market in the future
– Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
– Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample